IRIS
MAZZARINO, Maria Clorinda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.390
AS - Asia 1.772
EU - Europa 1.336
SA - Sud America 378
AF - Africa 263
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 9.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.219
SG - Singapore 887
CN - Cina 643
UA - Ucraina 413
IE - Irlanda 366
BR - Brasile 330
CI - Costa d'Avorio 187
IT - Italia 183
CA - Canada 149
RU - Federazione Russa 112
DE - Germania 74
VN - Vietnam 71
SE - Svezia 58
SN - Senegal 44
IN - India 40
GB - Regno Unito 35
AR - Argentina 22
MX - Messico 18
PL - Polonia 17
HK - Hong Kong 15
CH - Svizzera 14
FR - Francia 14
IQ - Iraq 14
IR - Iran 14
ZA - Sudafrica 14
BD - Bangladesh 13
NL - Olanda 13
ID - Indonesia 11
KR - Corea 11
TR - Turchia 11
CO - Colombia 10
UZ - Uzbekistan 10
AT - Austria 8
EC - Ecuador 8
EU - Europa 7
JP - Giappone 7
GR - Grecia 6
MA - Marocco 6
BE - Belgio 4
BG - Bulgaria 4
ES - Italia 4
FI - Finlandia 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
LB - Libano 2
OM - Oman 2
PK - Pakistan 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 9.150
Salva come PNG Salva come JPEG
Città #
Dallas 1.116
Santa Clara 672
Jacksonville 494
Singapore 428
Chandler 405
Dublin 367
Houston 314
Chicago 223
Abidjan 187
Boardman 180
Ashburn 122
Nanjing 117
Beijing 116
Toronto 112
Cambridge 108
Lawrence 107
Andover 106
Des Moines 78
Los Angeles 75
San Mateo 67
Catania 65
Hefei 51
Grafing 47
Wilmington 46
Dakar 44
Hebei 35
Nanchang 35
Buffalo 31
Saint Petersburg 30
The Dalles 27
São Paulo 26
Columbus 25
Jiaxing 25
Ho Chi Minh City 23
Council Bluffs 22
Shenyang 22
Civitanova Marche 19
San Francisco 19
Tianjin 17
Changsha 16
New York 16
Florence 15
Ottawa 15
Ardabil 13
Hong Kong 13
Leawood 13
Rio de Janeiro 13
Hanoi 12
Bremen 11
Brooklyn 11
Chennai 11
Warsaw 11
Augusta 10
Kunming 10
Norwalk 10
Seoul 10
Boston 9
Monmouth Junction 9
Seattle 9
Amsterdam 8
Hangzhou 8
Johannesburg 8
London 8
Montreal 8
Ningbo 8
Porto Alegre 8
Stockholm 8
Atlanta 7
Baghdad 7
Denver 7
Jinan 7
Mexico City 7
Moscow 7
Mumbai 7
Tokyo 7
Curitiba 6
Falls Church 6
Orem 6
Redondo Beach 6
Ankara 5
Belo Horizonte 5
Campinas 5
Goiânia 5
Misterbianco 5
Tashkent 5
Brasília 4
Brussels 4
Caxias do Sul 4
Dearborn 4
Den Haag 4
Guangzhou 4
Haiphong 4
Jakarta 4
Joinville 4
Kiev 4
Milan 4
Thái Bình 4
Vancouver 4
Viagrande 4
Washington 4
Totale 6.474
Salva come PNG Salva come JPEG
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 371
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance 310
Advances in targeting signal transduction pathways. 198
Absence of BRAF gene mutation in non-melanoma skin tumors 175
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients 138
Analysis of hepatitis C virus infection among health-care workers: an observational study 137
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 136
Analysis of BRAF mutation in primary and metastatic melanoma 125
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 125
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 125
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 125
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 122
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 116
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 116
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 115
B-cell neoplasia in the context of HCV infection: A distinct entity? 107
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 106
Proinflammatory circulating molecules in peripheral arterial disease 104
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 104
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 102
Detection of BRAF gene mutation in primary choroidal melanoma tissue 101
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 99
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 99
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 99
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 98
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 97
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 96
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 92
Vitamin D3: an ever green molecule 92
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 91
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 86
CD155/Neel-5 immunolocallization in melanocytic skin lesions 86
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 86
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 86
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 84
S100A7: A rAMPing up AMP molecule in psoriasis 84
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 83
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 83
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 83
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 82
Biological therapy induces expression changes in Notch pathway in psoriasis 82
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 82
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 81
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 81
IL2 and its receptors in elderly subjects on hemodialysis 80
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 79
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 78
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 78
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 78
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 78
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 78
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 77
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 77
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 76
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 76
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 76
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 76
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 75
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 75
CD155/Necl-5 immunolocalization in melanocytic skin lesions 75
Regulation of drug and immune resistance by YY1 in cancer 74
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 74
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 74
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip 73
High circulating levels of cytockines (IL6 and TNFα), adhesion molecules (VICAM-1 and ICAM-1) and selectines in patients with peripheral arterial disease at rest and after a treadmill-test 72
IL-18 nelle infezioni virali ricorrenti in età pediatrica 72
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 72
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 71
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 71
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 71
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 71
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 70
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 70
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 69
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 69
Insight into the role of microRNAs in brain tumors (review) 68
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 68
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 67
Modulation of Chitotriosidase During Macrophage Differentiation 67
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 67
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 66
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 66
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 65
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 64
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 64
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 64
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 63
Prognostic significance of YY1 in High Grade Lymphomas 63
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 63
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 62
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: Role of L-propionyl carnitine administration 62
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 61
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 60
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 60
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 58
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 58
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 57
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 56
Notch1 and TGFß1 regulate the expression of FOXP3 in melanoma cell lines: Preliminary observations 53
Understanding rituximab function and resistance: implications for tailored therapy 51
Totale 8.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021580 0 0 0 0 168 9 97 0 105 0 179 22
2021/2022793 102 107 0 8 126 6 113 24 75 0 15 217
2022/20231.167 117 53 20 105 124 212 2 202 269 12 40 11
2023/2024500 22 75 22 42 11 122 1 51 9 7 85 53
2024/20252.170 21 446 100 49 499 282 30 81 186 179 144 153
2025/20262.473 296 340 1.064 322 451 0 0 0 0 0 0 0
Totale 9.284